When was Q Bio founded?

Q Bio was founded in 2015 and raised its 1st funding round 1 year after it was founded.

Where is Q Bio located?

Q Bio is headquartered in Redwood City, United States. It is registered at Redwood City, California.

How many employees does Q Bio have?

As of Aug 31, 2026, the latest employee count at Q Bio is 36.

Is Q Bio a funded company?

Q Bio is a funded company, having raised a total of $80M across 4 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Nov 02, 2016.

When was the latest funding round of Q Bio?

Q Bio's latest funding was a $***** Series B round on Mar 26, 2024, with participation from 3 investors. Its primary sector is Healthcare IT. In United States, the Healthcare IT sector has seen $6.02B in funding in 2026 to date.

Where does Q Bio rank among its competitors?

Q Bio ranks 6th amongst 81 active competitors, of which 13 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was VedaPointe, which secured $4.03M in Jun, 2026.

Who are the top competitors of Q Bio?

Q Bio's top competitors include Briya, Emyria and MediData. Among them, VedaPointe secured the most recent funding round in June, 2026.

Q Bio - 2026 Company Profile, Team, Funding & Competitors

Q Bio is a series B company based in Redwood City (United States), founded in 2015 by Garry Choy and Michael Snyder. It operates as a Provider of clinical data management and analytics platform. Q Bio has raised $80M in funding from investors like Andreessen Horowitz, Khosla Ventures and Founders Fund. The company has 81 active competitors, including 13 funded and 6 that have exited. Its top competitors include companies like Briya, Emyria and MediData.

Company Details

Q Bio is a stealth mode startup that is working on developing solutions for clinical data management and analytics. The company is working on a solution that will provide insights regarding physiology by using data analytics over the diagnostic data collected from different sources. The company examined the biomarkers for different clinically relevant, genetic, chemical, and anatomical data.

Website: www.q.bio/
Social
Email ID: *****@q.bio
Phone Number: +1 **********
Registered Address: Redwood City, California

Key Metrics

Founded Year

2015

Location

Redwood City, United States

Stage

Series B

Total Funding

$80M in 4 rounds

Latest Funding Round

Series B, Mar 26, 2024, $*****

Investors

Andreessen Horowitz & 9 more

Ranked

6^th among 81 active competitors

Employee Count

36 as on Aug 31, 2026

Similar Companies

Briya & 109 more

View Q Bio's full profile

Q Bio is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Q Bio, Inc. CIN: 474704507 , United States, Active	Dec 26, 999	-	27 (As on Dec 31, 2024)	-

Q Bio has raised a total funding of $80M over 4 rounds. Its first funding round was on Nov 02, 2016. Its latest funding round was a Series B round on Mar 26, 2024 for $*****. 3 investors participated in its latest round. Q Bio has 10 institutional investors.

Here is the list of recent funding rounds of Q Bio:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 26, 2024	7527592	Series B	5026951	3181247	2175849	4825784
Apr 29, 2021	7486016	Series B	7909433	9706999	7893211	5723491
Feb 20, 2020	7128901	Series B	3503299	4371908	Andreessen Horowitz	Khosla Ventures & 5 more

Access funding benchmarks and valuations. Sign up today!

View details of Q Bio's funding rounds and investors

The founders of Q Bio are Garry Choy and Michael Snyder.

Here are the details of Q Bio's key team members:

Garry Choy: Co-Founder & CMO of Q Bio and founder of 1 other company. They serve on the board of 1 company.
Contact Info: 1 email address
Michael Snyder: Co-Founder of Q Bio.

Q Bio's Board of Directors

Q Bio's board has 3 active members. Clarissa Shen, Vijay Pande, Ph.D. and Terry Doyle are independent board members.

Here is the list of Q Bio's board of directors:

Name	Type	Representing	Status	Duration
Clarissa Shen	Independent board member	-	Current	2y 1m
e{sbdxw	Independent board member	-	Current	1y 6m
dglinjz	Independent board member	-	Current	4y 7m

View details of Q Bio's Founder profiles and Board Members

Q Bio's employee count trend

Q Bio has 36 employees as of Aug 26. Here is Q Bio's employee count trend over the years:

Uncover Q Bio's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Q Bio include Briya, Emyria and MediData. Here is the list of Top 10 competitors of Q Bio, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Briya 2021, New York City (United States), Series A	Cloud-based data collaborations and management tools	$17M	Amiti, Team8 & 3 others	58/100
2nd	Emyria 2018, Perth (Australia), Public	Provider of therapy and care planning solutions using interoperable clinical data	-	Tenmile, Tattarang & 3 others	57/100
3rd	MediData 2016, Cardiff (United Kingdom), Series A	Provider of interoperability solutions for healthcare professionals	$8.51M	WealthClub, Tricor Group & 31 others	54/100
4th	Seqster 2016, San Diego (United States), Series A	Online platform for managing and storing health records	$12M	Takeda & 1 others	52/100
5th	IDBS 1989, Guildford (United Kingdom), Acquired	Data management for research teams	$4.96M	Elaia	50/100
6th	Q Bio 2015, Redwood City (United States), Series B	Provider of clinical data management and analytics platform	$80M	Hanover Capital, 35V & 8 others	49/100
7th	Medchart 2015, Toronto (Canada), Series A	Provider of cloud-based medical interoperability platform for healthcare organizations	$17M	Crosslink Capital, Golden Ventures & 14 others	47/100
8th	Amida 2013, Washington, DC (United States), Funding Raised	Solution for healthcare providers to manage and share patient clinical data	-	Blue Delta Capital Partners	43/100
9th	EVO 2013, Atlanta (United States), Series A	Platform offering real-time predictive health analytics	$4.62M	Newark Venture Partners, Edison Partners	37/100
10th	VedaPointe 2019, St. Louis (United States), Series A	Digital data exchange and business intelligence platform for healthcare providers	$6.72M	-	36/100